TITLE

Rasburicase: Clearing Uric Acid from the Tumor Lysis Syndrome

AUTHOR(S)
Ershler, William B.
PUB. DATE
March 2011
SOURCE
Clinical Oncology Alert;Mar2011, Vol. 27 Issue 3, p19
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the safety and efficacy of using rasburicase (recombinant urate oxidase) for clearing uric acid in patients at high risk for tumor lysis syndrome (TLS) and children with leukemia and lymphoma. Pediatric and adult trials supporting the U.S. Food and Drug Administration's (FDA's) approval for such treatments are presented. Also discussed is the inclusion of rasburicase in the TLS treatment guidelines, its recommended dose and other critical factors affecting hyperuricemia.
ACCESSION #
59340610

 

Related Articles

  • Tümör lizis sendromu; tanı, izlem ve tedavide yeni yaklaşımlar. Celkan, Tiraje; Tüysüz, Gülen // Turkish Pediatrics Archive / Turk Pediatri Arsivi;sep2013, Vol. 48 Issue 3, p188 

    Tumor lysis syndrome is a clinical situation which occurs with the lysis of malignant cells and causes metabolic abnormalities that threatens life. These metabolic abnormalities are caused by the release of intracellular ions, nucleic acids, proteins and their metabolites from the instant...

  • Managing chemotherapy side effects: Tumor lysis syndrome. CURLER, KEVIN; THOMPSON, LISA A. // Oncology Nurse Advisor;January/February 2013, Vol. 4 Issue 1, p20 

    The article presents continuing education activity for oncology nurses concerning the management the tumor lysis syndrome (TLS), a serious complication of chemotherapy in the treatment of certain cancers. It explains that this discussion can help nurses understand the pathology of TLS, identify...

  • Tumor Lysis Syndrome: Prevention and Detection to Enhance Patient Safety. Maloney, Kristen; Denno, Mary // Clinical Journal of Oncology Nursing;Dec2011, Vol. 15 Issue 6, p601 

    Patient safety is at the forefront of health care and nursing practice. Oncology nurses strive to provide safe oncologic care in their management of cancer, treatments, and side effects. Oncologic emergencies such as tumor lysis syndrome (TLS), however, are serious complications of cancer and...

  • The Case of the Catabolic Catastrophe. Eisenberg, Seth // ONS Connect;Sep2012, Vol. 27 Issue 9, p19 

    The article presents a case study of a 57- year old man, with acute lymphoblastic leukemia (ALL) and a history of diabetes and congestive heart failure (CHF).

  • Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.  // Journal of Oncology Pharmacy Practice;Sep2010, Vol. 16 Issue 3, p205 

    The article discusses research investigating the use of rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome (TLS). Topics include an overview of the research methodology, which involved a review of TLS literature and metabolic imbalances, such as hyperuricemia,...

  • Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation. Hayes, Don; Breuer, Christopher; Horwitz, Edwin; Yates, Andrew; Tobias, Joseph; Shinoka, Toshiharu // Pediatric Cardiology;Dec2015, Vol. 36 Issue 8, p1748 

    The influence of posttransplant lymphoproliferative disorder (PTLD) on long-term survival in children after heart transplantation (HTx) is not well studied. The United Network for Organ Sharing database was queried from 1987 to 2013 for data on PTLD in relation to induction immunosuppression and...

  • Waldenström Macroglobulinemia with Hyperviscosity. Ershler, William B. // Clinical Oncology Alert;Aug2012, Vol. 28 Issue 8, p61 

    The article discusses a case of a 57-year-old male with progressive headaches, blurry vision, hearing loss, and episodes of confusion, diagnosed with Waldenström macroglobulinemia (WM). WM is an indolent lymphoma with accumulation within lypmphoplasmacytic marrow that secrete pentameric IgM,...

  • Biodistribution of Rhenium Cluster Complex K[ReS(CN)] in the Body of Laboratory Rats. Brylev, K.; Shestopalov, M.; Khripko, O.; Trunova, V.; Zvereva, V.; Wang, C.; Mironov, Yu.; Fedorov, V. // Bulletin of Experimental Biology & Medicine;Oct2013, Vol. 155 Issue 6, p741 

    We studied the biodistribution of luminescent octahedral rhenium cluster complex K[ReS(CN)], a promising agent for photodynamic therapy. It was shown that rhenium complex [ReS(CN)]- is mainly accumulated in the liver, the central organ of metabolism, and can be excreted by the kidneys. The...

  • Extramedullary Plasmacytoma of the Nasopharynx Treated with Surgery and Adjuvant Radiation: Case Report and Review of the Literature. Leibowitz, Jason M.; Cohen, Marc A.; Hashmi, Nazish; Mirza, Natasha; Abboud, Soo K. // Internet Journal of Otorhinolaryngology;2011, Vol. 12 Issue 2, p1 

    Purpose: Extramedullary plasmacytoma (EMP) is a rare neoplasm of plasma cell origin. Although the head and neck is the most common location of EMP, there are only a handful of cases reported in the nasopharynx. Design: Case report and review of the literature Results: A 50 year-old healthy male...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics